Curing science as AI's political promise

Tech firms and AI advocates routinely frame advances against diseases (like cancer) as the moral and political justification for risky, concentrated AI development. This rhetorical strategy can backfire when high‑profile claims fail to materialize or are revealed to be methodologically weak, eroding public trust and making regulation or funding battles more contentious. — If curing‑science rhetoric is revealed as unreliable, it will reshape public support, regulatory pressure, and funding priorities for AI and biomedical research.